Jupiter Life Line Hospitals Limited

Jupiter Life Line Hospitals Limited

Jupiter Life Line Hospitals Limited has informed the Exchange about the schedule of an earnings conference call to discuss the operational and financial performance for Q2 & H1 FY 27 on October 26, 2026.

Jupiter Life Line Hospitals Limited

Jupiter Life Line Hospitals Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2026, stating that the entire holding of the company is in Demat form and no rematerialisation request is received during the period.

Jupiter Life Line Hospitals Limited

Jupiter Life Line Hospitals Limited has informed the Exchange regarding the closure of the trading window for its designated persons and their immediate relatives due to the upcoming unaudited financial results for the quarter and half year ending September 30, 2026.

Jupiter Life Line Hospitals Limited

Jupiter Life Line Hospitals Limited has informed the Exchange about the schedule of an analyst/institutional investor meeting. The meeting will be held on September 28, 2026, from 1:00 pm to 5:00 pm, and will be attended by the company's officials. The meeting will be in-person and will refer to publicly available information, with no unpublished price-sensitive information intended to be discussed.

Jupiter Life Line Hospitals Limited

Jupiter Life Line Hospitals Limited has announced its Q1 FY27 earnings, with total income at INR411 crores, EBITDA at INR79.3 crores, and PAT at INR37.5 crores. The company's Dombivli Hospital has completed its first full quarter of operations, contributing to a INR9.5 crores drag on EBITDA. The other 3 operating hospitals and 3 upcoming projects are progressing on track.

Jupiter Life Line Hospitals Limited

Jupiter Life Line Hospitals Limited has informed the Exchange about the publication of unaudited financial results for the quarter ended June 30, 2026.

Jupiter Life Line Hospitals Limited

Jupiter Life Line Hospitals Limited has informed the Exchange about the link to the recording of the Analyst/Investor Conference Call for Q1 FY27.

Jupiter Life Line Hospitals Limited

Jupiter Life Line Hospitals Limited has intimated under Regulation 30(5) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements Regulations), 2015, that the Board of Directors has authorized Mr. Harshad Purani, Chief Financial Officer, and Dr. Ankit Thakker, Managing Director and Chief Executive Officer, to determine the materiality of events or information, and Ms. Suma Upparatti, Company Secretary and Compliance Officer, to make disclosures to the Stock Exchange(s).

Jupiter Life Line Hospitals Limited

Jupiter Life Line Hospitals Limited has released its Q1FY27 financial results, showing a total income of Rs 411.0 cr, EBITDA of Rs 78.4 cr, PBT of Rs 79.3 cr, and PAT of Rs 61.7 cr. The company's Dombivli hospital has completed its first full quarter of operations, with occupancy increasing steadily due to growing patient footfall and expansion of clinical services.

Jupiter Life Line Hospitals Limited

Jupiter Life Line Hospitals Limited has adopted a new line of business by acquiring 100% of the equity share capital of Sulcus Private Limited for ₹3.78 crore, and has also appointed a new Chief Financial Officer.

Jupiter Life Line Hospitals Limited

Jupiter Life Line Hospitals Limited has appointed Mr. Harshad Purani as Chief Financial Officer (CFO) of the company, effective July 31, 2026. The company has also approved the unaudited financial results for the quarter ended June 30, 2026, and has acquired 100% of the equity share capital of Sulcus Private Limited.

Jupiter Life Line Hospitals Limited

Jupiter Life Line Hospitals Limited has announced its unaudited financial results for the quarter ended June 30, 2026, along with the appointment of a new Chief Financial Officer and the acquisition of a subsidiary.

Jupiter Life Line Hospitals Limited

Jupiter Life Line Hospitals Limited has informed the Exchange about the schedule of a meet to discuss the operational and financial performance for Q1 FY 27.

Jupiter Life Line Hospitals Limited

Jupiter Life Line Hospitals Limited has submitted the Exchange a copy Scrutinizers report of Annual General Meeting held on July 17, 2026, and informed the Exchange regarding voting results.

Jupiter Life Line Hospitals Limited

Jupiter Life Line Hospitals Limited has fixed July 24, 2026, as the Record Date for determining the eligibility of equity shareholders entitled to the sub-division/stock split of the Company's equity shares. Each equity share having a face value of ₹10 will be sub-divided/split into 5 equity shares each fully paid up having a face value of ₹ 2.

Jupiter Life Line Hospitals Limited

Jupiter Life Line Hospitals Limited held its 24th Annual General Meeting on July 17, 2026, through video conferencing. The meeting was attended by 48 members, including promoters and public shareholders. The company provided e-voting facilities for shareholders to participate in the meeting. The meeting commenced at 11:00 A.M. and concluded at 11:33 A.M. The company's financial statements, auditor's report, and director's report were presented and taken as read with the consent of the members.

Jupiter Life Line Hospitals Limited

Jupiter Life Line Hospitals Limited has informed the Exchange about Certificate 74(5) under SEBI (Depositories and Participants) Regulations, 2018, indicating that the company's entire holding is in Demat form for the quarter ended June 30, 2026, with no rematerialisation requests received during the period.

Jupiter Life Line Hospitals Limited

Jupiter Life Line Hospitals Limited has informed the Exchange regarding the dispatch of a letter to shareholders with a weblink to access the AGM notice and annual report for the FY 2025-26.

Jupiter Life Line Hospitals Limited

Jupiter Life Line Hospitals Limited has informed the Exchange about the completion of dispatch of electronic copies of Annual Report for the Financial Year 2025-26 along with the Notice of the 24th AGM of the Company, scheduled to be held on Friday, July 17, 2026 through VC/OAVM.

Jupiter Life Line Hospitals Limited

Jupiter Life Line Hospitals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015. The trading window for dealing in the securities of the Company will remain closed for all the Designated Person of the Company and their Immediate Relatives from July 1, 2026, till 48 hours from the declaration of the Unaudited Financial Results (Standalone & Consolidated) of the Company to the Stock Exchanges for the quarter ending on June 30, 2026.